Open AccessFDAʼs Oncologic Drugs Advisory Committee Votes to Recommend Approval of Everolimus and Sunitinib for Pancreatic Metastatic Neuroendocrine Tumors
Author(s) -
Peggy Eastman
Publication year - 2011
Publication title -
oncology times
Language(s) - English
Resource type - Journals
eISSN - 1548-4688
pISSN - 0276-2234
DOI - 10.1097/01.cot.0000398392.83864.07
Subject(s) - everolimus , medicine , sunitinib , neuroendocrine tumors , adverse effect , placebo , population , oncology , cancer , pathology , alternative medicine , environmental health